Drug Utilization Research: Methods and Applications by Monique Elseviers Hardcov

Description: FREE SHIPPING UK WIDE Drug Utilization Research by Monique Elseviers, Björn Wettermark, Tanja Mueller, Marion Bennie, Katarina Gvozdanovic, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Sean MacBride-Stewart, Ria Benko Towards a better understanding of how medicines are used in society Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals. Readers of the second edition of Drug Utilization Research will find: New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilizationA section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugsA new section with case studies illustrating applications of DUR in different continentsDetailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes. FORMAT Hardcover CONDITION Brand New Author Biography Editors Monique Elseviers, Björn Wettermark, Tanja Mueller, Ria Benk, Marion Bennie, Katarina Gvozdanovi, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Seán MacBride-Stewart, Elisabetta Poluzzi, Lisa Pont, Hege Salvesen Blix, Gabriel Sanfélix-Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrovi, Indr— Treiokien—, Sabine Vogler Table of Contents List of contributors ix Preface to the second edition xvii Acknowledgements xix About the companion website xxiii Part 1 Introduction to drug utilization research 1 1 Introduction to drug utilization research 3Björn Wettermark, Monique Elseviers, Tanja Mueller, Anna Birna Almarsdottir, Ria Benkö, Marion Bennie, Irina Iaru, Katarina Gvozdanovic, Mikael Hoffmann, Verica Ivanovska, Seán MacBride-Stewart, Elisabetta Poluzzi, Lisa G. Pont, Hege Salvesen Blix, Gabriel Sanfelix-Gimeno, Gisbert W. Selke, Katja Taxis, Ana Tomas Petrovic, Indre Treciokiene, and Sabine Vogler Part 2 Methodology of drug utilization research 15 2.1 Research methods in drug utilization research 17Björn Wettermark, Indre Treciokiene, Sofia Kälvemark Sporrong, and Louise C. Druedahl 2.2 Qualitative methods in drug utilization research 25Louise C. Druedahl and Sofia Kälvemark Sporrong 2.3 Quantitative studies in drug utilization research 41Björn Wettermark, Monique Elseviers, and Cristina Mihaela Ghiucic 2.4 Descriptive studies in drug utilization research 51Cristina Mihaela Ghiciuc, Indre Treciokiene, Björn Wettermark, and Monique Elseviers 2.5 Analytical studies in drug utilization research 63Per-Jostein Samuelsen, Björn Wettermark, and Monique Elseviers 2.6 Intervention studies in drug utilisation research 73Tanja Mueller, Giampiero Mazzaglia, and Carlos E. Durán 2.7 Statistics in drug utilization research 82Monique Elseviers 2.8 Primary drug utilization data 95Tatiana Chama Borges Luz and Evalill Nilsson 2.9 Secondary drug utilization data 104Mohammadhossein Hajiebrahimi, Lisa G. Pont, and Kristina Garuoliene 2.10 Classification systems in drug utilization 115Hege Salvesen Blix, Stuart McTaggart, and Robert Vander Stichele 2.11 Measuring volumes in drug utilization 126Hege Salvesen Blix and Mikael Hoffmann 2.12 Measuring price and expenditure in drug utilization 137Sabine Vogler 2.13 Aggregate-level drug utilization analyses 148Indre Treciokiene and Claudia Garcia Serpa Osorio-de-Castro 2.14 Individual-level drug utilization analyses 158Lotte Rasmussen, Björn Wettermark, Mikael Hoffmann, and Douglas Steinke 2.15 Multilevel analyses in drug utilization research 169Juan Merlo and George Leckie 2.16 Visualization of drug utilization data 188Maria Matuz, Ria Benko, and Mikael Hoffmann 2.17 Artificial intelligence and machine learning in drug utilization research 205Maurizio Sessa, Saeed Shakibfar, Morten Andersen, and Jing Zhao 2.18 Ethics in drug utilization research 215Indre Treciokiene, Sofia Kälvemark Sporrong, Björn Wettermark, and Louise C. Druedahl Part 3 Applied drug utilization research 223 Section 3.1 Drug utilization research and health policy 225 3.1.1 Pharmaceutical policy and drug utilization: Definitions, concepts, and taxonomies 225Sabine Vogler and Anna Birna Almarsdóttir 3.1.2 Managed introduction of new medicines in healthcare systems 233Irina Iaru and Sabine Vogler 3.1.3 Promoting appropriate use of medicines in a healthcare system 248Marion Bennie, Amanj Kurdi, and Yared Santa-Ana-Téllez Section 3.2 Comparative drug utilization research 258 3.2.1 Introduction to comparative drug utilization research 258Seán MacBride-Stewart and Ana Tomas Petrovic 3.2.2 Comparison of drug utilization across countries 260Yared Santa-Ana Tellez and Monique Elseviers 3.2.3 Comparative drug utilization research comparing regions within countries 271Seán MacBride-Stewart 3.2.4 Comparison of drug utilization across different prescribers and different health care settings 280Seán MacBride-Stewart, Ksenia Zagorodnikova, and Irene Langner 3.2.5 Comparative drug utilization research comparing different patients 292Ana Tomas Petrovic and Mia von Euler Section 3.3 Drug utilization research in specific populations 303 3.3.1 Drug utilization in pregnant women 303Hedvig Nordeng and Marleen van Gelder 3.3.2 Drug utilization in the paediatric population 314Antonio Clavenna and Ingvild Odsbu 3.3.3 Drug utilization in older people 321Petra Denig and Katharina Schmidt-Mende Section 3.4 Drug utilization research in specific therapeutic areas 331 3.4.1 Introduction to methodological issues in specific therapeutic areas 331 3.4.2 Drug utilization research on cardiovascular medicines 332Elisabetta Poluzzi, Ana Tomas Petrovic, and Björn Wettermark 3.4.3 Drug utilization research on antibacterials 342Ria Benko and Samuel Coenen 3.4.4 Drugs utilization research in specific therapeutic areas - opioids 352Aleksi Hamina, Svetlana Skurtveit, and Mikael Hoffmann 3.4.5 Drug utilization research on selected psychotropics 363Jonathan Brett and Helga Zoega 3.4.6 Drug utilization research in the area of cancer drugs 373Tanja Mueller and Mikael Hoffmann Section 3.5 Adherence and drug utilization research 381 3.5.1 Introduction to medication adherence research 381Bernard Vrijens 3.5.2 Assessment of medication adherence in field research 387Monique Elseviers and Bernard Vrijens 3.5.3 Assessment of medication adherence in databases 397Gabriel Sanfélix Gimeno and Tanja Mueller 3.5.4 Interventions to improve medication adherence 406Catherine Goetzinger and Marie P. Schneider 3.5.5 Digital tools and medication adherence 419Alexandra L. Dima, Urska Nabergoj-Makovec, and Job F.M. van Boven Section 3.6 The role of drug utilization in the broader field of health research 428 3.6.1 Risk management and drug utilization research 428Giampiero Mazzaglia, Ippazio Cosimo Antonazzo, and Peter Mol 3.6.2 Pharmacovigilance and drug utilization research 437Katarina Gvozdanovic, Bernard Begauld, and Emanuel Raschi 3.6.3 The role of drug utilization in outcomes research 445Henrik Toft SØrensen, Gianluca Trifirò, and Evalill Nilsson 3.6.4 Pharmacoeconomics and drug utilization research 456Cara Usher, Kathleen Bennett, Lorenzo G. Mantovani, and Dyfrig Hughes 3.6.5 The environment and drug utilisation research 464Marmar Nekoro, Johanna Villén, and Ana Tomas Petrovic Section 3.7 Assessment and improvement of the quality of medicine use 482 3.7.1 Defining the quality of medicines use 482Seán MacBride-Stewart 3.7.2 Assessing the quality of medication use 488Petra Denig, Björn Wettermark, and Wade Thompson 3.7.3 Challenges in the quality of medicine use 498Katja Taxis and Carl Llor 3.7.4 Development and evaluation of interventions to improve the quality of medicine use 505Seán MacBride-Stewart and Katja Taxis 3.7.5 Implementation of interventions to enhance quality use of medicines 517Liset van Dijk and Marcia Vervloet 3.7.6 Patient perspectives 525Janine Traulsen and Janet Krska Part 4 Drug utilization research around the world 535 4.1 Introduction to drug utilization research around the world 537Monique Elseviers 4.2 Drug utilization research in Africa 541Ilse Truter, Johanita Burger, and Joseph Fadare 4.3 Drug utilization research in the Eastern Mediterranean region 546Mamoon A. Aldeyab, Zainab Said Al-Hashimy, and Maha Talaat 4.4 Drug utilization research in South-East Asia 551Anita Kotwani, Nithima Sumpradit, and Aminath Moomina 4.5 Drug utilization research in the Western Pacific Region 557Lisa G. Pont, Tuan Anh Nguyen, and Elizabeth Roughead 4.6 Drug utilization research in North America 563Juan M. Hincapie-Castillo, Shawn Bugden, and Ingrid Sketris 4.7 Drug utilization research in South and Central America 569Claudia Garcia Serpa Osorio-de-Castro, Luciane Cruz Lopes, and Carlos E. Durán 4.8 Drug utilization research in Europe 574Marion Bennie, Lotte Rasmussen, and Janne Sepp 4.9 The Glasgow Declaration 580Monique Elseviers, Björn Wettermark, Tanja Mueller, Anna Birna Almarsdottir, Ria Benkö, Marion Bennie, Irina Iaru, Katarina Gvozdanovic, Mikael Hoffmann, Verica Ivanovska, Seán MacBride-Stewart, Elisabetta Poluzzi, Lisa G. Pont, Hege Salvesen Blix, Gabriel Sanfelix-Gimeno, Gisbert W. Selke, Katja Taxis, Ana Tomas Petrovic, Indre Treciokiene, and Sabine Vogler Index 583 Details ISBN1119911656 Edition 2nd ISBN-13 9781119911654 Format Hardcover Subtitle Methods and Applications Edited by Ria Benko NZ Release Date 2023-10-19 ISBN-10 1119911656 Author Ria Benko Edition Description 2nd edition Replaces 9781118949788 Audience Professional & Vocational Year 2024 Pages 624 Publisher John Wiley and Sons Ltd Imprint Wiley-Blackwell Place of Publication Hoboken US Release Date 2024-08-29 Country of Publication United Kingdom Publication Date 2024-09-19 UK Release Date 2024-09-19 AU Release Date 2024-09-29 We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! 30 DAY RETURN POLICY No questions asked, 30 day returns! FREE DELIVERY No matter where you are in the UK, delivery is free. SECURE PAYMENT Peace of mind by paying through PayPal and eBay Buyer Protection TheNile_Item_ID:161620817;

Price: 103.99 GBP

Location: Melbourne

End Time: 2024-12-31T03:02:22.000Z

Shipping Cost: 4.29 GBP